Search
- Nov 4
Parker Institute for Cancer Immunotherapy's John Connolly on what he is seeing at #SITC23
John Connolly describes trends he is seeing in cell therapy, bi-specific engagers, myeloid checkpoint targets, and combinations.
- Jan 11
The latest on immunotherapy with John Connolly.
Parker Institute's John Connolly provides an update on the latest in cancer immunotherapy at #JPM23.
